首页> 美国卫生研究院文献>Acta Crystallographica. Section D Structural Biology >Introducing site-specific cysteines into nanobodies for mercury labelling allows de novo phasing of their crystal structures
【2h】

Introducing site-specific cysteines into nanobodies for mercury labelling allows de novo phasing of their crystal structures

机译:将位点特定的半胱氨酸引入纳米体内进行汞标记可以从头定相其晶体结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The generation of high-quality protein crystals and the loss of phase information during an X-ray crystallography diffraction experiment represent the major bottlenecks in the determination of novel protein structures. A generic method for introducing Hg atoms into any crystal independent of the presence of free cysteines in the target protein could considerably facilitate the process of obtaining unbiased experimental phases. Nanobodies (single-domain anti­bodies) have recently been shown to promote the crystallization and structure determination of flexible proteins and complexes. To extend the usability of nanobodies for crystallographic work, variants of the Nb36 nanobody with a single free cysteine at one of four framework-residue positions were developed. These cysteines could be labelled with fluorophores or Hg. For one cysteine variant (Nb36-C85) two nanobody structures were experimentally phased using single-wavelength anomalous dispersion (SAD) and single isomorphous replacement with anomalous signal (SIRAS), taking advantage of radiation-induced changes in Cys–Hg bonding. Importantly, Hg labelling influenced neither the interaction of Nb36 with its antigen complement C5 nor its structure. The results suggest that Cys–Hg-labelled nanobodies may become efficient tools for obtaining de novo phase information during the structure determination of nanobody–protein complexes.
机译:在X射线晶体衍射实验中,高质量蛋白质晶体的产生和相信息的丢失代表了确定新型蛋白质结构的主要瓶颈。一种与目标蛋白中游离半胱氨酸的存在无关的将Hg原子引入任何晶体的通用方法,可以极大地促进获得无偏实验相的过程。纳米抗体(单域抗体)最近被证明可以促进柔性蛋白质和复合物的结晶和结构测定。为了扩展纳米抗体在晶体学研究中的可用性,开发了Nb36纳米抗体的变异体,该变异体在四个骨架残基位置之一具有单个游离半胱氨酸。这些半胱氨酸可用荧光团或汞标记。对于一个半胱氨酸变异体(Nb36-C85),利用辐射诱导的Cys-Hg键合变化,利用单波长异常色散(SAD)和用异常信号(SIRAS)进行单一同构替代,对两个纳米抗体结构进行了实验相控。重要的是,汞标记既不影响Nb36与其抗原补体C5的相互作用,也不影响其结构。结果表明,Cys-Hg标记的纳米抗体可能成为在纳米抗体-蛋白质复合物的结构测定过程中获得从头相信息的有效工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号